Providers can justify billing for higher levels of service as patients’ CKD, hypertension progress. Hypertension with heart disease re-quires that the provider state that there is a causal ...
The MHRA (Medicines and Healthcare products Regulatory Agency) granted UK Marketing Authorisation for XOANACYL via the International Recognition Procedure (Route B) recognising its prior EU approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback